Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Drop in Short Interest

Posted by Casey Walker on Mar 28th, 2025

Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 49,700 shares, a decrease of 65.5% from the February 28th total of 143,900 shares. Based on an average daily trading volume, of 7,100,000 shares, the short-interest ratio is currently 0.0 days. Approximately 0.3% of the company’s shares are short sold.

Institutional Investors Weigh In On Biomerica

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC boosted its stake in Biomerica, Inc. (NASDAQ:BMRA – Free Report) by 24.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the period. Granahan Investment Management LLC owned about 3.59% of Biomerica worth $198,000 at the end of the most recent quarter. 22.28% of the stock is currently owned by institutional investors.

Biomerica Stock Performance

BMRA stock opened at $0.62 on Friday. Biomerica has a one year low of $0.24 and a one year high of $1.27. The firm has a market cap of $11.35 million, a PE ratio of -1.82 and a beta of -1.16. The firm’s 50 day moving average price is $0.67 and its 200-day moving average price is $0.45.

Biomerica (NASDAQ:BMRA – Get Free Report) last posted its earnings results on Tuesday, January 14th. The company reported ($0.06) EPS for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

Biomerica Company Profile

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.